American Association for Cancer Research (AACR) Annual Meeting 2026
San Diego, California, US 17 April 2026 - 22 April 2026
Ipilimumab plus nivolumab prolongs survival in melanoma with brain metastases
05 May 2026
byStephen Padilla
Treatment with ipilimumab plus nivolumab improves long-term survival in melanoma patients with asymptomatic brain metastases, according to the results of the NIBIT-M2 trial presented at AACR 2026.